Multiplex Immunofluorescence and Multispectral Imaging: Forming the Basis of a Clinical Test Platform for Immuno-Oncology

被引:33
|
作者
Hoyt, Clifford C. [1 ]
机构
[1] Akoya Biosci Inc, Malborough, MA USA
关键词
Predictive biomarkers; multiplex immunofluorescence; multispectral imaging; immuno-oncology; clinical workflow; image analysis; automated staining; spatial biology; LUNG-CANCER; EXPRESSION; ASSAY; IMMUNOHISTOCHEMISTRY; REPRODUCIBILITY; ASSOCIATION; NSCLC;
D O I
10.3389/fmolb.2021.674747
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As immuno-oncology (I/O) emerges as an effective approach in the fight against cancer, multispectral imaging of multiplex immunofluorescence (mIF) is maturing as an analytical platform. The timing is fortuitous. Due to health economic considerations surrounding the use of I/O, there is an urgent need for tests that accurately predict response to the growing list of available therapies. Multispectral mIF provides several advantages over other biomarker modalities by enabling deeper interrogation of the intricate biology within the tumor microenvironment, including detection of cell-to-cell spatial interactions that correlate with clinical outcomes. It also provides a practical path for generating reliable and reproducible results in a clinically suitable, high-throughput workflow. In this article, we (1) describe the principles behind multispectral mIF; (2) provide advice and recommendations on assay development and optimization and highlight characteristics of a well-performing assay; and (3) discuss the requirements for translating this approach into clinical practice.
引用
收藏
页数:14
相关论文
共 48 条
  • [31] Quantitative multiplexed imaging technologies for single-cell analysis to assess predictive markers for immunotherapy in thoracic immuno-oncology: promises and challenges
    Parra, Edwin Roger
    Ilie, Marius
    Wistuba, Ignacio I.
    Hofman, Paul
    BRITISH JOURNAL OF CANCER, 2023, 129 (09) : 1417 - 1431
  • [32] Tumor-Infiltrating Mast Cells in Angiosarcoma Correlate With Immuno-Oncology Pathways and Adverse Clinical Outcomes
    Tai, Sarah Beishan
    Lee, Elizabeth Chun Yong
    Lim, Boon Yee
    Kannan, Bavani
    Lee, Jing Yi
    Guo, Zexi
    Ko, Tun Kiat
    Ng, Cedric Chuan -Young
    Teh, Bin Tean
    Chan, Jason Yongsheng
    LABORATORY INVESTIGATION, 2024, 104 (03)
  • [33] The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
    Golan, Talia
    Milella, Michele
    Ackerstein, Aliza
    Berger, Ranaan
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [34] The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
    Talia Golan
    Michele Milella
    Aliza Ackerstein
    Ranaan Berger
    Journal of Experimental & Clinical Cancer Research, 36
  • [35] Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer
    Lee, Jong Lyul
    Roh, Seon Ae
    Kim, Chan Wook
    Kwon, Yi Hong
    Ha, Ye Jin
    Kim, Seon-Kyu
    Kim, Seon-Young
    Cho, Dong-Hyung
    Kim, Yong Sung
    Kim, Jin Cheon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (11) : 1341 - 1354
  • [36] The landscape of m6A regulators in esophageal cancer: molecular characteristics, immuno-oncology features, and clinical relevance
    Li, Zhe
    Zheng, Chunyan
    Huang, Liquan
    Yin, Xiaoyang
    Wang, Zhongtang
    Liu, Chengxin
    Li, Baosheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (24)
  • [37] Clinical outcomes and prognostic factors in metastatic nonclear cell renal cell carcinoma treated with immuno-oncology combination therapy
    Toyoda, Shingo
    Fukuokaya, Wataru
    Mori, Keiichiro
    Kawada, Tatsushi
    Katayama, Satoshi
    Nishimura, Shingo
    Maenosono, Ryoichi
    Tsujino, Takuya
    Adachi, Takahiro
    Hirasawa, Yosuke
    Saruta, Masanobu
    Komura, Kazumasa
    Nukaya, Takuhisa
    Yanagisawa, Takafumi
    Takahara, Kiyoshi
    Hashimoto, Takeshi
    Azuma, Haruhito
    Ohno, Yoshio
    Shiroki, Ryoichi
    Araki, Motoo
    Kimura, Takahiro
    Fujita, Kazutoshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (12) : 1336 - 1342
  • [38] Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era
    Byun, Hwa Kyung
    Kim, Nalee
    Yoon, Hong In
    Kang, Seok-Gu
    Kim, Se Hoon
    Cho, Jaeho
    Baek, Jong Geol
    Chang, Jong Hee
    Suh, Chang-Ok
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [39] Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
    Gastman, Brian
    Agarwal, Piyush K.
    Berger, Adam
    Boland, Genevieve
    Broderick, Stephen
    Butterfield, Lisa H.
    Byrd, David
    Fecci, Peter E.
    Ferris, Robert L.
    Fong, Yuman
    Goff, Stephanie L.
    Grabowski, Matthew M.
    Ito, Fumito
    Lim, Michael
    Lotze, Michael T.
    Mahdi, Haider
    Malafa, Mokenge
    Morris, Carol D.
    Murthy, Pranav
    Neves, Rogerio, I
    Odunsi, Adekunle
    Pai, Sara, I
    Prabhakaran, Sangeetha
    Rosenberg, Steven A.
    Saoud, Ragheed
    Sethuraman, Jyothi
    Skitzki, Joseph
    Slingluff, Craig L.
    Sondak, Vernon K.
    Sunwoo, John B.
    Turcotte, Simon
    Yeung, Cecilia C. S.
    Kaufman, Howard L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [40] The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
    Gonzalez-Ericsson, Paula, I
    Stovgaard, Elisabeth S.
    Sua, Luz F.
    Reisenbichler, Emily
    Kos, Zuzana
    Carter, Jodi M.
    Michiels, Stefan
    Le Quesne, John
    Nielsen, Torsten O.
    Laenkholm, Anne-Vibeke
    Fox, Stephen B.
    Adam, Julien
    Bartlett, John M. S.
    Rimm, David L.
    Quinn, Cecily
    Peeters, Dieter
    Dieci, Maria, V
    Vincent-Salomon, Anne
    Cree, Ian
    Hida, Akira, I
    Balko, Justin M.
    Haynes, Harry R.
    Frahm, Isabel
    Acosta-Haab, Gabriela
    Balancin, Marcelo
    Bellolio, Enrique
    Yang, Wentao
    Kirtani, Pawan
    Sugie, Tomoharu
    Ehinger, Anna
    Castaneda, Carlos A.
    Kok, Marleen
    McArthur, Heather
    Siziopikou, Kalliopi
    Badve, Sunil
    Fineberg, Susan
    Gown, Allen
    Viale, Giuseppe
    Schnitt, Stuart J.
    Pruneri, Giancarlo
    Penault-Llorca, Frederique
    Hewitt, Stephen
    Thompson, E. Aubrey
    Allison, Kimberly H.
    Symmans, William F.
    Bellizzi, Andrew M.
    Brogi, Edi
    Moore, David A.
    Larsimont, Denis
    Dillon, Deborah A.
    JOURNAL OF PATHOLOGY, 2020, 250 (05) : 667 - 684